Heron Therapeutics' Forbes acquires 3,874 shares

The transaction lists $0.36 per share for 1,102 common shares delivered or withheld for payment of exercise price or tax liability.

Rhea-AI Filing Summary

At Heron Therapeutics, Inc., EVP, Chief Development Officer William P. Forbes reported the conversion of 3,874 restricted stock units into 3,874 common shares on October 19, 2026. Each unit is a contingent right to one common share, and the units vest in 16 equal quarterly installments beginning one quarter after the January 19, 2024 grant date. Forbes also had 1,102 common shares delivered or withheld for payment of exercise price or tax liability, and reported 19,372 restricted stock units following the transaction.

Insider Trade Summary

3,874 shares exercised/converted

Exercise 3 txns

Insider Forbes William P

Role EVP, Chief Development Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F2	3,874	$0.00	$0.00
Exercise	Common Stock F1	3,874	--	--
Exercise Price or Tax Liability	Common Stock	1,102	$0.36	$396.72

Holdings After Transaction: Restricted Stock Units — 19,372 contracts (Direct); Common Stock — 243,945 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
2. F2. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

Key Figures

Restricted stock units converted: 3,874 restricted stock units Common shares acquired: 3,874 shares Shares delivered or withheld: 1,102 shares +3 more

6 metrics

Restricted stock units converted 3,874 restricted stock units October 19, 2026

Common shares acquired 3,874 shares On conversion of restricted stock units on October 19, 2026

Shares delivered or withheld 1,102 shares For payment of exercise price or tax liability on October 19, 2026

Price per share listed $0.36 per share For the 1,102 shares delivered or withheld on October 19, 2026

Restricted stock units following transaction 19,372 restricted stock units Reported after the October 19, 2026 transaction

Vesting installments 16 equal quarterly installments Beginning one quarter after the January 19, 2024 grant date

Key Terms

restricted stock unit, contingent right, equal quarterly installments

3 terms

restricted stock unit financial

"Each restricted stock unit represents a contingent right"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right financial

"contingent right to receive one share of common stock"

equal quarterly installments financial

"vest in 16 equal quarterly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HRTX shares did William P. Forbes receive from restricted stock units?

William P. Forbes acquired 3,874 common shares on October 19, 2026, corresponding to 3,874 restricted stock units; each unit represents a contingent right to one common share.

What price was listed for William P. Forbes's HRTX share delivery or withholding?

The transaction lists $0.36 per share for 1,102 common shares delivered or withheld for payment of exercise price or tax liability on October 19, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/21/2026 - 12:02 PM EDT Accepted by SEC EDGAR 10/21/2026 - 12:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forbes William P

(Last) (First) (Middle)

25 FENTON MAIN STREET

SUITE 300

(Street)

CARY NORTH CAROLINA 27511

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HERON THERAPEUTICS, INC. /DE/ [ HRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Development Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/19/2026		M		3,874	A	(1)	245,047	D
Common Stock	10/19/2026		F		1,102	D	$0.36	243,945	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	10/19/2026		M			3,874	(2)	(2)	Common Stock	3,874	$0	19,372	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock.

2. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

	/s/Kathryn Lester Attorney-in-fact for William P. Forbes	10/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)